Orally delivered salmon calcitonin-loaded solid lipid nanoparticles prepared by micelle-double emulsion method via the combined use of different solid lipids

Nanomedicine

Volumn 8, Issue 7, 2013, Pages 1085-1100

  Chen, Chunhui ^a   Fan, Tingting ^a   Jin, Yun ^a   Zhou, Zhou ^a   Yang, Yang ^a   Zhu, Xi ^a   Zhang, Zhi Rong ^a   Zhang, Qiang ^b   Huang, Yuan ^a  

^a SICHUAN UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

bioavailability; combined solid lipid; micelle double emulsion technique; salmon calcitonin; solid lipid nanoparticle; uptake

Indexed keywords

CLATHRIN; LIPID EMULSION; SALCATONIN; SOLID LIPID NANOPARTICLE; STEARIC ACID; TRIACYLGLYCEROL; TRILAURIN; TRIMYRISTIN; TRIPALMITIN; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; CALCIUM BLOOD LEVEL; CAVEOLA; CELL STRAIN CACO 2; CYTOTOXICITY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG UPTAKE; ENDOCYTOSIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VIVO STUDY; INTERNALIZATION; INTESTINE FLUID; INTRACELLULAR TRANSPORT; MICELLE; PRIORITY JOURNAL; SIMULATION; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84879655628     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.141     Document Type: Article

References (40)

1. Antosova Z, Mackova M, Kral V, Macek T. Therapeutic application of peptides and proteins: parenteral forever? Trends Biotechnol. 27, 11 628-635 (2009).
2. Lee HE, Lee MJ, Park CR et al. Preparation and characterization of salmon calcitonin-sodium triphosphate ionic complex for oral delivery. J. Control. Release 143(2), 251-257 (2010).
3. Lee YH, Sinko PJ. Oral delivery of salmon calcitonin. Adv. Drug Deliver. Rev. 42(3), 225-238(2000). (Pubitemid 30645779)
4. Müller RH, Ruhl D, Runge SA. Biodegradation of solid lipid nanoparticles as a function of lipase incubation time. Int. J. Pharm. 144(1), 115-121 (1996). (Pubitemid 27039349)
5. Uner M, Yener G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int. J. Nanomed. 2(3), 289-300 (2007). (Pubitemid 350047774)
6. Olbrich C, Kayser O, Müller RH. Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)-effect of surfactants, storage time and crystallinity. Int. J. Pharm. 237(1-2), 119-128 (2002). (Pubitemid 34310485)
7. Severino P, Andreani T, Macedo AS et al. Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery. J. Drug Deliv. doi:10.1155/2012/750891 (2012) (Epub ahead of print).
8. Gallarate M, Trotta M, Battaglia L, Chirio D. Preparation of solid lipid nanoparticles from W/O/W emulsions: preliminary studies on insulin encapsulation. J. Microencapsul. 26(5), 394-402 (2009).
9. Cui F, Shi K, Zhang L, Tao A, Kawashima Y. Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. J. Control. Release 114(2), 242-250 (2006). (Pubitemid 44291843)
10. Morel S, Ugazio E, Cavalli R, Gasco MR. Thymopentin in solid lipid nanoparticles. Int. J. Pharm. 132(1-2), 259-261 (1996). (Pubitemid 26158724)
11. Yang R, Gao R, Li F, He H, Tang X. The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process. Drug Dev. Ind. Pharm. 37(2), 139-148 (2011).
12. Cheng WP, Thompson C, Ryan SM, Aguirre T, Tetley L, Brayden DJ. In vitro and in vivo characterisation of a novel peptide delivery system: amphiphilic polyelectrolyte-salmon calcitonin nanocomplexes. J. Control. Release 147(2), 289-297 (2010).
13. Wang J, Chow D, Heiati A, Shen WC. Reversible lipidization for the oral delivery of salmon calcitonin. J. Control. Release 88(3), 369-380 (2003). (Pubitemid 36331879)
14. Sinko PJ, Smith CL, McWhorter LT, Stern W, Wagner E, Gilligan JP. Utility of pharmacodynamic measures for assessing the oral bioavailability of peptides. 1. Administration of recombinant salmon calcitonin in rats. J. Pharm. Sci. 84(11), 1374-1378 (1995).
15. Oh DH, Chun KH, Jeon SO, Kang JW, Lee S. Enhanced transbuccal salmon calcitonin (sCT) delivery: effect of chemical enhancers and electrical assistance on in vitro sCT buccal permeation. Eur. J. Pharm. Biopharm. 79(2), 357-363 (2011).
16. Cheng W, Satyanarayanajois S, Lim LY. Aqueous-soluble, non-reversible lipid conjugate of salmon calcitonin: synthesis, characterization and in vivo activity. Pharm. Res. 24(1), 99-110 (2007). (Pubitemid 44902575)
17. Liu J, Gong T, Fu H et al. Solid lipid nanoparticles for pulmonary delivery of insulin. Int. J. Pharm. 356(1-2), 333-344 (2008).
18. Coello A, Meijide F, Núñez ER, Tato JV. Aggregation behavior of bile salts in aqueous solution. J. Pharm. Sci. 85, 9-15 (1996). (Pubitemid 26029066)
19. Fan Y, Li X, Zhou Y et al. Improved intestinal delivery of salmon calcitonin by water-in-oil microemulsions. Int. J. Pharm. 416(1), 323-330 (2011).
20. Bhaskar K, Mohan CK, Lingam M, Reddy VP, Venkateswarlu V, Rao YM. Development of nitrendipine controlled release formulations based on SLN and NLC for topical delivery: in vitro and ex vivo characterization. Drug Dev. Ind. Pharm. 34(7), 719-725 (2008). (Pubitemid 351962344)
21. Kullavadee KO, Uracha R, Smith SM. Effect of surfactant on characteristics of solid lipid nanoparticles (SLN). Adv. Mater. Res. 364, 313-316 (2012).
22. Illing A, Unruh T. Investigation on the flow behavior of dispersions of solid triglyceride nanoparticles. Int. J. Pharm. 284(1-2), 123-131 (2004). (Pubitemid 39349145)
23. Prego C, Torres D, Fernandez-Megia E, Novoa-Carballal R, Quinoa E, Alonso MJ. Chitosan-PEG nanocapsules as new carriers for oral peptide delivery-effect of chitosan pegylation degree. J. Control. Release 111(3), 299-308 (2006).
24. Liu J, Gong T, Wang C, Zhong Z, Zhang Z. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: Preparation and characterization. Int. J. Pharm. 340(1-2), 153-162 (2007). (Pubitemid 47044961)
25. Roda A, Hofmann AF, Mysels KJ. The influence of bile salt structure on self-association in aqueous solutions. J. Biol. Chem. 258(10), 6362-6370 (1983). (Pubitemid 13106811)
26. Schweitzer B, Felippe AC, Dal Bo A, Minatti E, Zanette D, Lopes A. Sodium dodecyl sulfate promoting a cooperative association process of sodium cholate with bovine serum albumin. J. Colloid Interf. Sci. 298(1), 457-466 (2006).
27. Mithani SD, Bakatselou V, Tenhoor CN, Dressman JB. Estimation of the increase in solubility of drugs as a function of bile salt concentration. Pharm. Res. 13(1), 163-167 (1996). (Pubitemid 26076314)
28. Lee MJ, Seo DY, Lee HE, Choi GJ. Therapeutic effect of chitosan modification on salmon calcitonin-loaded PLGA nanoparticles. Korean J. Chem. Eng. 28(6), 1406-1411 (2011).
29. Gaumet M, Gurny R, Delie F. Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size. Eur. J. Pharm. Sci. 36(4-5), 465-473 (2009).
30. Sharma VK, Diwan A, Sardana S, Dhall V. Solid lipid nanoparticles system: an overview. Int. J. Res. Pharm. Sci. 2(3), 450-461 (2011).
31. Anna RS. Stability of lipid excipients in solid lipid nanoparticles. Adv. Drug Deliv. Rev. 59, 411-418 (2007).
32. Garcia-Fuentes M, Prego C, Torres D, Alonso MJ. A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery. Eur. J. Pharm. Sci. 25(1), 133-143 (2005). (Pubitemid 40602203)
33. Song KH, Chung SJ, Shim CK. Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts. J. Control. Release 106(3), 298-308 (2005).
34. Zhang X, Sun M, Zheng A, Cao D, Bi Y, Sun J. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Eur. J. Pharm. Sci. 45(5), 632-638 (2012).
35. Kukowska-Latallo JF, Candido KA, Cao ZY et al. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 65(12), 5317-5324 (2005). (Pubitemid 40827344)
36. Fernando LP, Kandel PK, Yu J, McNeill J, Ackroyd PC, Christensen KA. Mechanism of cellular uptake of highly fluorescent conjugated polymer nanoparticles. Biomacromolecules 11(10), 2675-2682 (2010).
37. Ho SP, Storch J. Common mechanisms of monoacylglycerol and fatty acid uptake by human intestinal Caco-2 cells. Am. J. Physiol. Cell Physiol. 281(4), C1106-C1117 (2001).
38. Hu Y, Litwin T, Nagaraja AR et al. Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles. Nano Lett. 7(10), 3056-3064 (2007). (Pubitemid 350132930)
39. Tomoda H, Kishimoto Y, Lee YC. Temperature effect on endocytosis and exocytosis by rabbit alveolar macrophages. J. Biol. Chem. 264(26), 15445-15450 (1989). (Pubitemid 19242918)
40. Manjunath K, Venkateswarlu V. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. J. Control. Release 107(2), 215-228 (2005). (Pubitemid 41319672) for New Drug RandD